在患有与PLCG2相关的免疫失调症的患者中,早期发病的双底性肺气
Annika Sundlof1, Justin Nathan1, Glenn S Gerhard1
1Temple University Hospital, 3401 North Broad Street, Philadelphia, PA 19140, United States.
Respiratory medicine case reports
|January 15, 2026
概括
在PLCG2基因的突变导致APLAID,导致感染和免疫问题的条件. 这份病例报告详细介绍了患有PLCG2突变的患者早期发作的肺气,扩大了已知的APLAID谱.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
- 肺部病理学 肺部病理学
背景情况:
- 脂酶C玛2 (PLCG2) 突变与自身炎症性,主要抗体缺乏症和自身免疫性疾病 (APLAID) 谱系疾病有关.
- APLAID通常表现为复发性感染,抗体缺乏,免疫失调和皮肤问题.
研究的目的:
- 报告一个具有 PLCG2 突变的个体中早期发病的双底性肺气的新奇病例.
- 扩大PLCG2相关疾病的已知临床表现.
- 讨论这种表型的潜在机制和管理策略.
主要方法:
- 一个患有早期发病的肺气,频繁的呼吸道感染和免疫球蛋白缺乏症的患者的病例报告.
- 基因检测用于识别PLCG2突变.
- 关于PLCG2相关表型和治疗选择的文献综述.
主要成果:
- 这名患者被诊断出患有PLCG2突变.
- 这名患者出现了早期发病的双肺气,这是APLAID的以前未被描述的表现.
- 肺并没有与α-1抗素缺乏有关.
结论:
- 这种情况扩大了PLCG2突变的表型谱,包括COPD/肺.
- 基因检测对于诊断APLAID及其各种表现至关重要.
- 在APLAID中肺气的潜在机制包括慢性感染或与自身免疫的关联.
更多相关视频
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
COPD: Pathogenesis and Clinical Features
1.8K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.8K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.5K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K
Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.6K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.6K
Pneumonia II: Pathophysiology
2.6K
The pathophysiology of pneumonia involves the following steps:
2.6K


